Aprea Therapeutics, Inc. - APRE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.436M
QoQ value delta ($000)
-$943K (-39.64%)
Implied price effect (QoQ)
-42.37%
Shares
Total shares
1,695,512
QoQ shares delta
+76,661 (+4.74%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (APRE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 27 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
AIGH Capital Management LLC 316 370,541 0.08%
Murchinson Ltd. 290 340,139 0.05%
SPHERA FUNDS MANAGEMENT LTD. 230 270,000 0.04%
Nantahala Capital Management, LLC 175 205,760 0.01%
DRW Securities, LLC 102 120,651 0.0%
MORGAN STANLEY 65 77,030 0.0%
VANGUARD GROUP INC 49 58,086 0.0%
CITADEL ADVISORS LLC 43 51,041 0.0%
JANE STREET GROUP, LLC 39 46,621 0.0%
GEODE CAPITAL MANAGEMENT, LLC 34 40,950 0.0%
BNP PARIBAS FINANCIAL MARKETS 23 27,332 0.0%
LPL Financial LLC 22 26,052 0.0%
XTX Topco Ltd 20 24,304 0.0%
HighTower Advisors, LLC 11 13,864 0.0%
BlackRock, Inc. 7 8,504 0.0%
Tower Research Capital LLC (TRC) 6 7,827 0.0%
BANK OF AMERICA CORP /DE/ 2 3,299 0.0%
UBS Group AG 2 2,461 0.0%
GROUP ONE TRADING LLC 0 577 0.0%
OSAIC HOLDINGS, INC. 0 300 0.0%
SBI Securities Co., Ltd. 0 15 0.0%
WealthCollab, LLC 0 158 0.0%